Novo Nordisk, Red Cross team up to tackle chronic diseases in conflict zones

from Reuters - Thomson Reuters Foundation
Published on 18 Apr 2018 View Original

COPENHAGEN, April 18 (Reuters) - Danish drugmaker Novo Nordisk and aid agency Red Cross have teamed up to try to improve the treatment of chronic diseases among the millions affected by conflicts and humanitarian crises in countries such as Syria and Yemen.

Read more on the Thomson Reuters Foundation.

Reuters - Thomson Reuters Foundation:
For more humanitarian news and analysis, please visit